<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04518917</url>
  </required_header>
  <id_info>
    <org_study_id>AT010753-02S1</org_study_id>
    <nct_id>NCT04518917</nct_id>
  </id_info>
  <brief_title>Sing for Your Saunter - Dementia Supplement</brief_title>
  <acronym>SFYS-D</acronym>
  <official_title>Sing for Your Saunter: Using Self-generated Rhythmic Cues to Enhance Gait in Parkinson's - Dementia Supplement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older adults, and particularly those with Parkinson disease (PD), may experience walking&#xD;
      difficulties that negatively impact their daily function and quality of life. People that&#xD;
      have PD plus dementia are also likely to experience walking difficulties. This project will&#xD;
      examine the impact of music and mentally singing on walking performance, with a goal of&#xD;
      understanding what types of rhythmic cues are most helpful. Pilot work from the investigators&#xD;
      suggests that imagined, mental singing (i.e., singing in head) while while walking helps&#xD;
      people walk faster with greater stability, whereas walking to music also helps people walk&#xD;
      faster but with reduced stability.&#xD;
&#xD;
      In this study, the investigators will recruit people who have PD plus dementia. The&#xD;
      investigators will compare walking while mentally singing, walking while singing out loud,&#xD;
      and walking while listening to music, using personalized cues tailored to each person's&#xD;
      walking performance. The investigators hypothesize temporal variability of gait will be lower&#xD;
      in the mental singing and singing conditions compared to listening to music; and that mental&#xD;
      singing, singing, and listening to music will elicit similar improvements in stride length.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During this observational study, participants will attend one visit in the laboratory. The&#xD;
      visit will include participants wearing wearable sensors during the following tasks: walking&#xD;
      with no cues (UNCUED), walking while listening to music (MUSIC), walking while singing out&#xD;
      loud (SINGING), and walking while mentally singing (MENTAL SINGING). The wearable sensors&#xD;
      will measure gait parameters including gait speed, stride length, and stride time&#xD;
      variability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stride Time Variability</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured with wearable sensors by APDM Wearable Technology</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride length</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured with wearable sensors by APDM Wearable Technology</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">23</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Parkinson Disease Dementia</condition>
  <arm_group>
    <arm_group_label>Parkinson disease plus dementia</arm_group_label>
    <description>Participants will have a diagnosis of Parkinson disease plus dementia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mentally Singing</intervention_name>
    <description>Participants sing their song in their head and match their footfalls to the beat.</description>
    <arm_group_label>Parkinson disease plus dementia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Listening to music</intervention_name>
    <description>Participants listen to their song and match their footfalls to the beat.</description>
    <arm_group_label>Parkinson disease plus dementia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Singing</intervention_name>
    <description>Participants will sing their song out loud and match their footfalls to the beat.</description>
    <arm_group_label>Parkinson disease plus dementia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Recruitment of participants with PD plus dementia will primarily be through existing&#xD;
        studies in the Department of Neurology at Washington University School of Medicine.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  at least 30 years of age&#xD;
&#xD;
          -  diagnosis of idiopathic, typical Parkinson disease according to the UK Brain Bank&#xD;
             Criteria&#xD;
&#xD;
          -  Hoehn &amp; Yahr stages 2-3 (mild to moderate disease severity)&#xD;
&#xD;
          -  normal or corrected hearing&#xD;
&#xD;
          -  stable on all PD medications for at least 2 months prior to study entry&#xD;
&#xD;
          -  dementia as defined by a Clinical Dementia Rating (CDR) score of 0.5-1.0 (very mild to&#xD;
             mild dementia)&#xD;
&#xD;
          -  score of â‰¥ 1 on the MDS-UPDRS-III Item #10 indicating observable gait impairment&#xD;
&#xD;
          -  a score of 1 or less on item #7 on the freezing of gait questionnaire&#xD;
&#xD;
          -  able to walk for 10 continuous minutes independently&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diagnosis of any other neurological condition&#xD;
&#xD;
          -  unstable medical or concomitant illnesses or psychiatric conditions which, in the&#xD;
             opinion of the investigators, would preclude successful participation&#xD;
&#xD;
          -  cardiac problems that interfere with ability to safely participate (i.e., uncontrolled&#xD;
             congestive heart failure, myocardial infarction in past 6 months, complex cardiac&#xD;
             arrhythmias, significant left ventricular dysfunction, dyspnea on exertion, chest pain&#xD;
             or pressure, resting tachycardia (&gt;100 beats/min); uncontrolled BP (resting systolic&#xD;
             BP &gt;160 mmHg or diastolic BP &gt;100 mmHg))&#xD;
&#xD;
          -  orthopedic problems in the lower extremities or spine that may limit walking (i.e.,&#xD;
             severe arthritis, spinal stenosis)&#xD;
&#xD;
          -  uncontrolled tremor or dyskinesia while on PD medications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gammon Earhart</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martha Hessler</last_name>
    <phone>3142861478</phone>
    <email>Mjhessler@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kerri Rawson</last_name>
    <phone>3142731053</phone>
    <email>Rawson@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington University School of Medicine Program in Physical Therapy</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha Hessler</last_name>
      <phone>314-286-1478</phone>
      <email>mjhessler@wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kerri Rawson, PhD</last_name>
      <phone>314-273-1053</phone>
      <email>rawson@wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Gammon M Earhart, PT, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 15, 2020</study_first_submitted>
  <study_first_submitted_qc>August 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2020</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>Gammon M Earhart</investigator_full_name>
    <investigator_title>Director, Program in Physical Therapy</investigator_title>
  </responsible_party>
  <keyword>Parkinson disease</keyword>
  <keyword>Music</keyword>
  <keyword>Mental singing</keyword>
  <keyword>Gait</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

